US Patent Issued to Cartesian Therapeutics on Nov. 18 for "Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both Type 1 and Type IV hypersensitivity" (California Inventor)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,167, issued on Nov. 18, was assigned to Cartesian Therapeutics Inc. (Frederick, Md.).

"Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both Type 1 and Type IV hypersensitivity" was invented by Roberto A. Maldonado (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods and related compositions for concomitantly, locally administering immunosuppressants and doses of therapeutic macromolecules for reducing Type I and Type IV hypersensitivity."

The patent was filed on March 9, 2022, under Application No. 17/690,437.

*For further in...